ARCHIVES

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

This article is from The Cancer Letter archive.

Vol. 04 No. 37 | September 15, 1978

Download PDF Visit The Full Archive

Related Articles

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

Bepler To Lead Karmanos Cancer Institute

January 29, 2010

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

March 14, 2008

NCI prepares for third hearing on conflicts of interest.

June 18, 2004